{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T23:08:20Z","timestamp":1767136100758,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd012121","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T00:00:00Z","timestamp":1638748800000}}],"reference-count":35,"publisher":"Wiley","issue":"12","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012121.pub2","type":"journal-article","created":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T06:03:40Z","timestamp":1638770620000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Carisbamate add-on therapy for drug-resistant focal epilepsy"],"prefix":"10.1002","volume":"2021","author":[{"given":"Chuansen","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Neurology; Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University; Haikou, Hainan China"},{"name":"Department of Neurology; First Affiliated Hospital, Guangxi Medical University; Nanning China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinou","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Neurology; First Affiliated Hospital, Guangxi Medical University; Nanning China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Neurology; First Affiliated Hospital, Guangxi Medical University; Nanning China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Bresnahan","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics; Institute of Systems, Molecular and Integrative Biology, University of Liverpool; Liverpool UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsty J","family":"Martin-McGill","sequence":"additional","affiliation":[{"name":"The Centre for Advancing Practice; Health Education England; Liverpool UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2021,12,6]]},"reference":[{"issue":"20","key":"10.1002\/14651858.CD012121.pub2-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1212\/01.wnl.0000334751.89859.7f","article-title":"Randomized, controlled, dose-ranging trial of carisbamate for partial-onset seizures","volume":"71","author":"Faught","year":"2008","journal-title":"Neurology"},{"issue":"Suppl 6","key":"10.1002\/14651858.CD012121.pub2-BIB0002|cit2","first-page":"330, Abstract n","article-title":"A double-blind, placebo-controlled, dose ranging study to evaluate the efficacy and tolerability of carisbamate (RWJ-333369) as adjunctive therapy in patients with refractory partial epilepsy","volume":"48","author":"Faught","year":"2007","journal-title":"Epilepsia"},{"issue":"4","key":"10.1002\/14651858.CD012121.pub2-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1111\/j.1528-1167.2010.02960.x","article-title":"A randomized, double-blind, placebo-controlled study of the efficacy, safety, and tolerability of adjunctive carisbamate treatment in patients with partial-onset seizures","volume":"52","author":"Halford","year":"2011","journal-title":"Epilepsia"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD012121.pub2-BIB0004|cit4","first-page":"14","article-title":"Efficacy, safety, and tolerability of carisbamate 800 and 1200 mg\/day as adjunctive therapy in patients with partial onset seizures; randomized, double-blind, placebo-controlled trial","volume":"51","author":"Halford","year":"2010","journal-title":"Epilepsia"},{"issue":"Suppl 7","key":"10.1002\/14651858.CD012121.pub2-BIB0005|cit5","first-page":"106","article-title":"Carisbamate as adjunctive treatment of partial onset seizures in adults in two international, randomized, placebo-controlled trials","volume":"49","author":"Sperling","year":"2008","journal-title":"Epilepsia"},{"issue":"3","key":"10.1002\/14651858.CD012121.pub2-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/j.1528-1167.2009.02318.x","article-title":"Carisbamate as adjunctive treatment of partial onset seizures in adults in two randomized, placebo-controlled trials","volume":"51","author":"Sperling","year":"2010","journal-title":"Epilepsia"},{"issue":"Suppl 7","key":"10.1002\/14651858.CD012121.pub2-BIB0007|cit7","first-page":"106","article-title":"Carisbamate as adjunctive treatment of partial onset seizures in adults in two international, randomized, placebo-controlled trials","volume":"49","author":"Sperling","year":"2008","journal-title":"Epilepsia"},{"issue":"3","key":"10.1002\/14651858.CD012121.pub2-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/j.1528-1167.2009.02318.x","article-title":"Carisbamate as adjunctive treatment of partial onset seizures in adults in two randomized, placebo-controlled trials","volume":"51","author":"Sperling","year":"2010","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD012121.pub2-BIB0009|cit9","unstructured":"A randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate the efficacy, safety, and tolerability of carisbamate as adjunctive therapy in subjects with partial onset seizures, followed by an open-label extension study www.clinicaltrialsregister.eu\/ctr-search\/search?query=eudract_number:2008-007688-17"},{"key":"10.1002\/14651858.CD012121.pub2-BIB0010|cit10","unstructured":"Carisbamate Retention Study (CaReS): comparative study on the long term effectiveness, safety and tolerability of carisbamate compared to two other frequently prescribed anti-epileptic drugs (AEDs) in patients with epilepsy clinicaltrials.gov\/ct\/show\/NCT00563459"},{"key":"10.1002\/14651858.CD012121.pub2-BIB0011|cit11","unstructured":"Effectiveness and safety study for RWJ-333369 as adjunctive therapy in Korean and Japanese patients with partial onset seizures clinicaltrials.gov\/show\/NCT00697762"},{"issue":"11","key":"10.1002\/14651858.CD012121.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1111\/j.1528-1167.2006.00815.x","article-title":"Pharmacokinetic interaction study between the new antiepileptic and CNS drug RWJ-333369 and carbamazepine in healthy adults","volume":"47","author":"Chien","year":"2006","journal-title":"Epilepsia"},{"issue":"7","key":"10.1002\/14651858.CD012121.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1111\/j.1528-1167.2007.01037.x","article-title":"An interaction study between the new antiepileptic and CNS drug carisbamate (RWJ-333369) and lamotrigine and valproic acid","volume":"48","author":"Chien","year":"2007","journal-title":"Epilepsia"},{"issue":"6","key":"10.1002\/14651858.CD012121.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s002100000319","article-title":"Structure, function and pharmacology of voltage-gated sodium channels","volume":"362","author":"Denac","year":"2000","journal-title":"Naunyn-Schmiedeberg's Archives of Pharmacology"},{"issue":"3","key":"10.1002\/14651858.CD012121.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1528-1167.2007.01278.x","article-title":"Effects of carisbamate (RWJ-333369) in two models of genetically determined generalized epilepsy, the GAERS and the audiogenic Wistar AS","volume":"49","author":"Francois","year":"2008","journal-title":"Epilepsia"},{"issue":"10","key":"10.1002\/14651858.CD012121.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1111\/j.1528-1167.2008.01657.x","article-title":"A new potential AED, carisbamate, substantially reduces spontaneous motor seizures in rats with kainate-induced epilepsy","volume":"49","author":"Grabenstatter","year":"2008","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD012121.pub2-BIB0017|cit17","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT"},{"key":"10.1002\/14651858.CD012121.pub2-BIB0018|cit18","unstructured":"Higgins JP Green S Cochrane Handbook for Systematic Reviews of Interventions version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1\/"},{"issue":"11","key":"10.1002\/14651858.CD012121.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1046\/j.1528-1157.2002.40501.x","article-title":"Voltage-gated sodium channels in epilepsy","volume":"43","author":"Kohling","year":"2002","journal-title":"Epilepsia"},{"issue":"9","key":"10.1002\/14651858.CD012121.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1212\/01.WNL.0000142991.14507.B5","article-title":"Injuries due to seizures in persons with epilepsy: a population-based study","volume":"63","author":"Lawn","year":"2004","journal-title":"Neurology"},{"issue":"8","key":"10.1002\/14651858.CD012121.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.neuropharm.2011.07.022","article-title":"Carisbamate (RWJ-333369) inhibits glutamate transmission in the granule cell of the dentate gyrus","volume":"61","author":"Lee","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1002\/14651858.CD012121.pub2-BIB0022|cit22","unstructured":"Lefebvre C Glanville J Briscoe S Littlewood A Marshall C Technical Supplement to Chapter 4: Searching for and selecting studies. In: Higgins JPT, Thomas J, Chandler J, Cumpston MS, Li T, Page MJ, Welch VA (eds). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021 Available from www.training.cochrane.org\/handbook"},{"issue":"1","key":"10.1002\/14651858.CD012121.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.eplepsyres.2008.09.006","article-title":"Carisbamate, a novel neuromodulator, inhibits voltage-gated sodium channels and action potential firing of rat hippocampal neurons","volume":"83","author":"Liu","year":"2009","journal-title":"Epilepsy Research"},{"issue":"4","key":"10.1002\/14651858.CD012121.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1124\/dmd.106.011940","article-title":"The absorption, metabolism, and excretion of the novel neuromodulator RWJ-333369 (1,2-ethanediol, [1-2-chlorophenyl]-, 2-carbamate, [S]-) in humans","volume":"35","author":"Mannens","year":"2007","journal-title":"Drug Metabolism and Disposition"},{"issue":"Suppl 7","key":"10.1002\/14651858.CD012121.pub2-BIB0025|cit25","first-page":"S195","article-title":"Current challenges in the management of epilepsy","volume":"17","author":"Privitera","year":"2011","journal-title":"American Journal of Managed Care"},{"key":"10.1002\/14651858.CD012121.pub2-BIB0026|cit26","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"issue":"1-2","key":"10.1002\/14651858.CD012121.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0920-1211(02)00065-7","article-title":"The clinical impact of new antiepileptic drugs after a decade of use in epilepsy","volume":"50","author":"Schmidt","year":"2002","journal-title":"Epilepsy Research"},{"issue":"6","key":"10.1002\/14651858.CD012121.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S1474-4422(08)70108-X","article-title":"Intractable epilepsy: management and therapeutic alternatives","volume":"7","author":"Schuele","year":"2008","journal-title":"Lancet Neurology"},{"key":"10.1002\/14651858.CD012121.pub2-BIB0029|cit29","unstructured":"Sch\u00fcnemann HJ Oxman AD Vist GE Higgins JPT Deeks JJ Glasziou P Chapter 12: Interpreting results and drawing conclusions. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1\/"},{"issue":"3","key":"10.1002\/14651858.CD012121.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1528-1167.2009.02318.x","article-title":"Carisbamate as adjunctive treatment of partial onset seizures in adults in two randomized, placebo-controlled trials","volume":"51","author":"Sperling","year":"2010","journal-title":"Epilepsia"},{"issue":"Suppl 7","key":"10.1002\/14651858.CD012121.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1528-1167.2011.03121.x","article-title":"Standards for epidemiologic studies and surveillance of epilepsy","volume":"52","author":"Thurman","year":"2011","journal-title":"Epilepsia"},{"issue":"9","key":"10.1002\/14651858.CD012121.pub2-BIB0032|cit32","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.MR000007.pub3","article-title":"Individual participant data meta-analyses compared with meta-analyses based on aggregate data","author":"Tudur Smith","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"Spec No 1","key":"10.1002\/14651858.CD012121.pub2-BIB0033|cit33","first-page":"5S376","article-title":"Quality-of-life scales for patients with drug-resistant partial epilepsy","volume":"160","author":"Villeneuve","year":"2004","journal-title":"Revue Neurologique"},{"issue":"11","key":"10.1002\/14651858.CD012121.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1111\/j.1528-1167.2006.00814.x","article-title":"Pharmacokinetics of the new antiepileptic and CNS drug RWJ-333369 following single and multiple dosing to humans","volume":"47","author":"Yao","year":"2006","journal-title":"Epilepsia"},{"issue":"3","key":"10.1002\/14651858.CD012121.pub2-BIB0035|cit35","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012121","article-title":"Carisbamate add-on therapy for drug-resistant partial epilepsy","author":"Lu","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T00:17:14Z","timestamp":1664410634000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD012121.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Epilepsy Group","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,12,6]]},"references-count":35,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,12]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012121.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,6]]}}}